Federal Research Product Commercialization Act

Summary

Federal Research Product Commercialization Act - Amends the Public Health Service Act to require that a biomedical research project relating to the development of a drug, device, or other tangible product may not be supported by the National Institutes of Health (NIH) unless there is in effect an agreement ensuring that any commercial parties involved in the project make the product available to the public at a reasonable price and that the commercial parties pay NIH royalties reasonably related to the amounts NIH spent with respect to the product.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 11 March 1993

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 11 March 1993

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 11 March 1993

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.